In more than 262,000 UK Biobank participants, a 5-marker cardiometabolic score was linked to graded risk at each step toward CKM multimorbidity.
|Articles|September 28, 2020
Pharmacy Times: Weekly Lineup
This week on Pharmacy Times, there are a number of hot topics that we will be posting throughout the week.
Advertisement
This week on Pharmacy Times, there are a number of hot topics that we will be posting throughout the week, including:
- An exclusive podcast interview with Russell Procopio, executive vice president of Long-Term Care Pharmacy, where we will be discussing a recent study regarding long-term care outcomes and cost.
- A video interview with Brian Nightengale, president of Good Neighbor Pharmacy, on the value of diversifying a pharmacy’s business through meaningful health and wellness services.
- On Wednesday, Pharmacy Times will feature a clinical overview of ubrogepant (Ubrelvy, Allergan), which is indicated to treat acute migraines with or without aura in adults. Ubrogepant works as a calcitonin gene-related peptide receptor antagonist. CGRP is protein known to be released during migraine attacks, and Ubrogepant reduces CGRP activity by preventing it from binding to its receptors. The article will provide a review of clinical trials, contraindications, warnings, and precautions, as well as counseling information for pharmacists.
Advertisement
Related to this article
Two IDWeek 2026 studies link influenza vaccination to fewer ICU admissions in older adults and fewer emergency visits in children.
The approval offers a once-weekly basal insulin treatment option for patients, reducing the frequency of injections.
Early data suggest the 7 PCV20-added serotypes are causing a smaller share of invasive pneumococcal disease in children younger than 2 years.
In pooled CORALreef data, patients with eGFR below 60 had a 65.9% placebo-adjusted LDL-C reduction at week 24, with safety comparable to placebo.
A PharmD candidate reflects on the small, evidence-backed daily habits that helped her thrive—not just survive—through pharmacy school's most demanding years.
Understanding local health care priorities is essential to developing meaningful solutions.
Pharmacy Times will feature experts on kidney function assessment, IgG4-related disease, emerging CKD therapies, and gaps in cardiorenal care.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Flu Vaccination Linked to Fewer Severe Outcomes in Older Adults, Fewer ED Visits in Children
2
FDA Approves Awiqli, Once-Weekly Insulin, for Children Aged 10 Years and Older With T2D
3
Combined Cardiometabolic Biomarker Burden Tracks CKM Progression
4
Kidney Week 2026: What to Know for Nephrology's Biggest Meeting
5